150 related articles for article (PubMed ID: 32338203)
21. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
[TBL] [Abstract][Full Text] [Related]
22. Combination of serum CST4 and DR-70 contributes to early diagnosis of colorectal cancer.
Cai L; Tu M; Yin X; Zhang S; Zhuang W; Xia Y; Zhang Y; Zhang L; Yu L; Chi L; Huang Y
Clin Chim Acta; 2022 Jun; 531():318-324. PubMed ID: 35500878
[TBL] [Abstract][Full Text] [Related]
23. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.
Corbo C; Cevenini A; Salvatore F
Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089
[TBL] [Abstract][Full Text] [Related]
24. Serum proteomic profiling for the early diagnosis of colorectal cancer.
Zhu D; Wang J; Ren L; Li Y; Xu B; Wei Y; Zhong Y; Yu X; Zhai S; Xu J; Qin X
J Cell Biochem; 2013 Feb; 114(2):448-55. PubMed ID: 22961748
[TBL] [Abstract][Full Text] [Related]
25. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
[TBL] [Abstract][Full Text] [Related]
26. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
[TBL] [Abstract][Full Text] [Related]
27. Selected reaction monitoring for colorectal cancer diagnosis using a set of five serum peptides identified by BLOTCHIP
Uchiyama K; Naito Y; Yagi N; Mizushima K; Higashimura Y; Hirai Y; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Handa O; Ishikawa T; Takagi T; Konishi H; Nonaka D; Asada K; Lee LJ; Tanaka K; Kuriu Y; Nakanishi M; Otsuji E; Itoh Y
J Gastroenterol; 2018 Nov; 53(11):1179-1185. PubMed ID: 29497816
[TBL] [Abstract][Full Text] [Related]
28. Noninvasive molecular biomarkers for the detection of colorectal cancer.
Kim HJ; Yu MH; Kim H; Byun J; Lee C
BMB Rep; 2008 Oct; 41(10):685-92. PubMed ID: 18959813
[TBL] [Abstract][Full Text] [Related]
29. Case-controlled identification of colorectal cancer based on proteomic profiles and the potential for screening.
Huijbers A; Mesker WE; Mertens BJ; Bladergroen MR; Deelder AM; van der Burgt YE; Tollenaar RA
Colorectal Dis; 2014 Nov; 16(11):907-13. PubMed ID: 25243779
[TBL] [Abstract][Full Text] [Related]
30. Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
Ludvigsen M; Thorlacius-Ussing L; Vorum H; Moyer MP; Stender MT; Thorlacius-Ussing O; Honoré B
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422974
[TBL] [Abstract][Full Text] [Related]
31. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
[TBL] [Abstract][Full Text] [Related]
32. Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients.
Pietrzyk Ł; Wdowiak P
Adv Med Sci; 2019 Sep; 64(2):402-408. PubMed ID: 31352222
[TBL] [Abstract][Full Text] [Related]
33. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
[TBL] [Abstract][Full Text] [Related]
34. Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer.
Ghazanfar S; Fatima I; Aslam M; Musharraf SG; Sherman NE; Moskaluk C; Fox JW; Akhtar MW; Sadaf S
J Proteomics; 2017 Jan; 152():33-40. PubMed ID: 27989943
[TBL] [Abstract][Full Text] [Related]
35. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
[TBL] [Abstract][Full Text] [Related]
36. Serum FBLN1 and STK31 as biomarkers of colorectal cancer and their ability to noninvasively differentiate colorectal cancer from benign polyps.
Watany MM; Elmashad NM; Badawi R; Hawash N
Clin Chim Acta; 2018 Aug; 483():151-155. PubMed ID: 29715435
[TBL] [Abstract][Full Text] [Related]
37. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review.
Li B; Gan A; Chen X; Wang X; He W; Zhang X; Huang R; Zhou S; Song X; Xu A
PLoS One; 2016; 11(5):e0155095. PubMed ID: 27158984
[TBL] [Abstract][Full Text] [Related]
39. Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Benner A; Schrotz-King P; Brenner H
Mol Oncol; 2020 Jan; 14(1):8-21. PubMed ID: 31652396
[TBL] [Abstract][Full Text] [Related]
40. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
